San Francisco, California Clinical Trials

A listing of San Francisco, California clinical trials actively recruiting patient volunteers.

Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 58 clinical trials
PQ Test Trial ( Do not edit)  

Primary Objective:Primary population (former smokers cohort):Evaluate the efficacy of itepekimab compared with placebo on the annualized rate of acute moderate-or-severe COPD exacerbations in former smokers with moderate-to-severe COPDSecondary Objectives:Primary population (former smokers cohort):Evaluate the efficacy of itepekimab compared with placebo on pulmonary function in former smokers with moderate-to-severe COPDEvaluate the efficacy …

Abington Neurological Associates Willow Grove
 (8.3 away)
  • 0 views
  • 01 Apr, 2024
  • +3 other locations
Investigating the Effect of Single-session Sauna Use on Body Temperature

Whole-body hyperthermia (WBH) to an internal temperature of 38.5 C (101.3 F) using an infrared heating device has been associated with significant reductions in clinical depression. This prior work utilized a WBH medical device that is manufactured in Germany, is not FDA approved, and is not widely available. The goal …

University of California San Francisco
 (1.4 away) Contact site
  • 0 views
  • 16 Feb, 2024
  • 1 location
Safety Pharmacokinetics and Preliminary Efficacy of Isatuximab in Patients Awaiting Kidney Transplantation

Primary Objectives: Phase 1: To characterize the safety and tolerability of isatuximab in kidney transplant candidates. Phase 2: To evaluate the efficacy of isatuximab in desensitization of patients awaiting kidney transplantation. Secondary Objectives: Phase 2: To characterize the safety profile of isatuximab in kidney transplant candidates. To characterize the pharmacokinetic …

chronic kidney disease
nephropathy
isatuximab
sar650984
kidney transplant
Investigational Site Number 8400003
 (2.2 away) Contact site
  • 0 views
  • 16 Feb, 2024
  • +1 other locations
JSI-1187-01 Monotherapy and in Combination With Dabrafenib for Advanced Solid Tumors With MAPK Pathway Mutations

This is a Phase 1 study of JSI-1187 as monotherapy and in combination with dabrafenib for the treatment of advanced solid tumors with MAPK pathway mutations, including mutations that cause MAPK pathway hyperactivation.

metastasis
gene fusion
gilbert's syndrome
metastatic melanoma
measurable disease
University of California Helen Diller Family Comprehensive Cancer Center
 (1.8 away) Contact site
  • 0 views
  • 16 Feb, 2024
  • +3 other locations
Continuous Versus Cyclical OCP Use in PCOS (CCOUP)

The mainstay treatment for females with Polycystic Ovary Syndrome (PCOS) has long been a combination of an oral contraceptive pill or OCP (containing both estrogen and progestin) along with an anti-androgen medication (such as Spironolactone) to not only prevent chronic anovulation but also suppress elevated testosterone levels and its clinical …

Accepts healthy volunteers
University of California, San Francisco
 (1.8 away) Contact site
  • 0 views
  • 04 Apr, 2022
  • +1 other locations
Testing the Addition of a Type of Drug Called Immunotherapy to the Usual Chemotherapy Treatment for Non-small Cell Lung Cancer ALCHEMIST Chemo-IO Study

This phase III ALCHEMIST trial compares the addition of pembrolizumab to usual chemotherapy versus usual chemotherapy for the treatment of stage IB, II, or IIIA non-small cell lung cancer that has been removed by surgery. Immunotherapy with monoclonal antibodies, such as pembrolizumab, may help the body's immune system attack the …

carboplatin
stage iia lung squamous cell carcinoma ajcc v7
pembrolizumab
paclitaxel
monoclonal antibody therapy
California Pacific Medical Center-Pacific Campus
 (1.4 away) Contact site
  • 0 views
  • 16 Feb, 2024
  • +358 other locations
A Study of Donanemab (LY3002813) in Participants With Early Alzheimer's Disease (TRAILBLAZER-ALZ 2)

The reason for this study is to see how safe and effective the study drug donanemab is in participants with early Alzheimer's disease.

alzheimer's disease
mini-mental state examination
florbetapir
flortaucipir
positron emission tomography
Univ of California San Francisco
 (1.8 away) Contact site
  • 0 views
  • 16 Feb, 2024
  • +85 other locations
A Phase 3 Study to Evaluate Efficacy and Safety of AL001 in Frontotemporal Dementia (INFRONT-3)

A phase 3 double blind, placebo controlled study evaluating the efficacy and safety of AL001 in participants at risk for or with frontotemporal dementia due to heterozygous mutations in the progranulin gene.

progranulin
dementia
aphasia
pick's disease
University of California San Francisco
 (2.2 away) Contact site
  • 0 views
  • 16 Feb, 2024
  • +46 other locations
NA-831 Atazanavir and Dexamethasone Combination Therapy for the Treatment of COVID-19 Infection

This Phase 2/3 trial evaluates four treatment strategies for non-critically ill hospitalized participants (not requiring ICU admission and/or mechanical ventilation) with SARS CoV-2 infection, in which participants will receive NA-831 or Atazanavir with or without Dexamethasone.

cervical cap
acute respiratory syndrome (sars)
complete blood count
critically ill
electrocardiogram
Coronavirus Research Testing Site
 (1.8 away) Contact site
  • 0 views
  • 16 Feb, 2024
  • +29 other locations
trial_with_no_inv

Test trial

Alameda site
 (9.7 away) Contact site
  • 0 views
  • 06 Dec, 2023
  • +1 other locations